Posted by europerep on May 17, 2015, at 8:06:40
In reply to Re: Viibryd in Europe, posted by joe f on May 17, 2015, at 7:11:34
Yeah, based on what I've heard and read, it doesn't seem to be a smashing success. I don't recall any poster here on PB who has had real success with it, and I remember reading that even its touted side effect profile is less good than was suggested before it was released.
Maybe it's more of a new first-line drug, with slim (if any) advantages for treatment-resistant patients.
poster:europerep
thread:1078997
URL: http://www.dr-bob.org/babble/20150407/msgs/1079023.html